Related Experiment Video
Updated: Jul 15, 2026

Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Focal atrophy and cerebrovascular disease increase dementia risk among cognitively normal older adults
Caterina Rosano1, Howard J Aizenstein, Minjie Wu
1School of Public Health, Department of Epidemiology, University of Pittsburgh, Pennysylvania, USA. RosanoC@edc.pitt.edu
Background And Purpose:
This study investigated the association of medial temporal lobe (MTL) atrophy and cerebrovascular disease (white matter hyperintensities [WMH], subclinical infarcts) with the risk of developing Alzheimer's disease (AD) among cognitively normal older adults.
Methods:
Risk of developing AD was examined for 155 cognitively normal older adults (77.4 years, 60% women, 81% white). The MTL volumes and the presence of WMH and of subclinical infarcts were determined from brain magnetic resonance imaging (MRI) at the beginning of the study. Follow-up cognitive evaluations (average 4.3 years) identified those who developed AD.
Results:
The presence of either MTL atrophy or subclinical infarcts was independently and significantly associated with a greater risk to develop AD (OR [95% CI]: 4.4 [1.5, 12.3] and 2.7 [1.0, 7.1], respectively). In addition, those participants with both MTL atrophy and at least one brain infarct had a 7-fold increase in the risk of developing AD (OR [95% CI]: 7.0 [1.5, 33.1]), compared to those who had neither of these conditions.
Conclusions:
In cognitively normal older adults, markers of neurodegeneration (as reflected by MTL atrophy) and of cerebrovascular disease (as reflected by infarcts on MRI) independently contribute to the risk to develop AD.
Insights
Medial temporal lobe atrophy and brain infarcts, indicators of neurodegeneration and cerebrovascular disease, significantly increase Alzheimer's disease risk in cognitively normal older adults.
Area of Science:
- Neurology
- Neuroimaging
- Geriatrics
Background:
- Alzheimer's disease (AD) risk factors in cognitively normal individuals are crucial for early detection.
- Medial temporal lobe (MTL) atrophy and cerebrovascular disease are potential early AD indicators.
Purpose of the Study:
- To investigate the association between MTL atrophy, cerebrovascular disease markers (white matter hyperintensities [WMH], subclinical infarcts), and Alzheimer's disease (AD) risk.
- To assess these associations in a cohort of cognitively normal older adults.
Main Methods:
- 155 cognitively normal older adults underwent brain MRI to assess MTL volumes and detect WMH and subclinical infarcts.
- Participants were followed for an average of 4.3 years with cognitive evaluations to identify AD development.
- Statistical analysis examined the independent and combined risks associated with MTL atrophy and infarcts.
Main Results:
- MTL atrophy and subclinical infarcts were independently associated with a significantly higher risk of developing AD.
- Individuals with both MTL atrophy and at least one brain infarct showed a 7-fold increased risk of AD.
- White matter hyperintensities (WMH) were also assessed but their specific association with AD risk was not detailed in the provided results.
Conclusions:
- Both neurodegenerative markers (MTL atrophy) and cerebrovascular disease markers (infarcts) independently contribute to AD risk in cognitively normal older adults.
- The combined presence of MTL atrophy and infarcts substantially elevates AD risk.
- These findings highlight the importance of considering both neurodegeneration and cerebrovascular health in predicting AD development.
More Related Videos
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Related Concept Videos
Dementia l: Introduction
Alzheimer Disease l: Introduction
Dementia
The progression of dementia is generally gradual.
Alzheimer Disease ll: Pathophysiology
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Cognitive Development During Adulthood